• 제목/요약/키워드: Renal neoplasms

검색결과 47건 처리시간 0.029초

Safety of Laparoscopic Radical Gastrectomy in Gastric Cancer Patients with End-Stage Renal Disease

  • Lee, Hayemin;Park, Cho Hyun;Park, Seung Man;Kim, Wook;Chin, Hyung Min;Kim, Jin Jo;Song, Kyo Young;Kim, Sung Geun;Jun, Kyong Hwa;Kim, Jeong Goo;Lee, Han Hong;Lee, Junhyun;Kim, Dong Jin
    • Journal of Gastric Cancer
    • /
    • 제18권3호
    • /
    • pp.287-295
    • /
    • 2018
  • Purpose: The surgical outcomes of end-stage renal disease (ESRD) patients undergoing radical gastrectomy for gastric cancer were inferior compared with those of non-ESRD patients. This study aimed to evaluate the short- and long-term surgical outcomes of ESRD patients undergoing laparoscopic gastrectomy (LG) and open gastrectomy (OG) for gastric cancer. Materials and Methods: Between 2004 and 2014, 38 patients (OG: 21 patients, LG: 17 patients) with ESRD underwent gastrectomy for gastric cancer. Comparisons were made based on the clinicopathological characteristics, surgical outcomes, and long-term survival rates. Results: No significant differences were noted in the clinicopathological characteristics of either group. LG patients had lower estimated blood loss volumes than OG patients (LG vs. OG: 94 vs. 275 mL, P=0.005). The operation time and postoperative hospital stay were similar in both the groups. The postoperative morbidity for LG and OG patients was 41.1% and 33.3%, respectively (P=0.873). No significant difference was observed in the long-term overall survival rates between the 2 groups (5-year overall survival, LG vs. OG: 82.4% vs. 64.7%, P=0.947). Conclusions: In ESRD patients, LG yielded non-inferior short- and long-term surgical outcomes compared to OG. Laparoscopic procedures might be safely adopted for ESRD patients who can benefit from the advantages of minimally invasive surgery.

편평상피세포 폐암과 동반된 막성사구체신염 1예 (A Case of the Membranous Glomerulonephritis Associated with Squamous Cell Lung Cancer)

  • 조유리;서영진;김무곤;이준엽;정승혜;류헌모;윤현대;이인희;안기성;신태림;현대성;이상채;조창호
    • Tuberculosis and Respiratory Diseases
    • /
    • 제51권2호
    • /
    • pp.178-183
    • /
    • 2001
  • 악성종양에 동반되는 신증후군은 비교적 드문 부신생물증후군이며 가장 흔한 종양은 폐암, 특히 소세포 폐암이다. 그러나 비세포성 폐암과 동반된 경우는 매우 드물고 국내에서는 보고된 바가 없다. 저자들은 막성사구체신염으로 치료 중 편평상피세포 폐암이 발현된 1예를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

  • PDF

Childhood Cancer Incidence and Survival 1985-2009, Khon Kaen, Thailand

  • Wiangnon, Surapon;Jetsrisuparb, Arunee;Komvilaisak, Patcharee;Suwanrungruang, Krittika
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권18호
    • /
    • pp.7989-7993
    • /
    • 2014
  • Background: The Khon Kaen Cancer Registry (KKCR) was established in 1984. Previous population-based incidences and survivals of childhood cancer in Thailand were determined using a short cancer registration period. Materials and Methods: Data were retrieved of all children residing in Khon Kaen, between 0-15 years, diagnosed as having cancer and registered in the KKCR (1985-2009). The follow-up censored date was December 31, 2012. The childhood cancers were classified into 12 diagnostic groups, according to the International Classification of Childhood Cancer. The incidence was calculated by the standard method. Survival of childhood cancer was investigated using the KKCR population-based registration data and overall survival calculated using the Kaplan Meier method. Results: In the study period, 912 newly diagnosed cases of childhood cancer were registered. The respective mean and median age was 6.4 (SD=4.6) and 6 (0-14) years. The age-peak for incidence was 0-4 years. The age-standardized rate (ASR) was 83 per million. Leukemia was the most common cancer (N=360, ASR 33.8) followed by neoplasms of the central nervous system (CNS, N=150, ASR 12.8) and lymphoma (N=79, ASR 7.0). The follow-up duration totaled 101,250 months. The death rate was 1.11 per 100 person-months (95%CI: 1.02 -1.20). The 5-year overall survival was 52% (95%CI: 53-56.9) for all cancers. The respective 5-year overall survival for (1) acute lymphoblastic leukemia (ALL), (2) acute non-lymphoblastic leukemia (ANLL), (3) lymphoma, (4) germ cell tumors, (5) renal tumors, (6) retinoblastoma, (7) soft tissue tumors, (8) CNS tumors, (9) bone tumors, (10) liver tumors, and (11) neuroblastoma was (1) 51%, (2) 37%, (3) 63%, (4) 74%, (5) 67%, (6) 55%, (7) 46%, (8) 44%, (9) 36%, (10) 34%, and (11) 25%. Conclusions: The incidence of childhood cancer is lower than those of western countries. Respective overall survival for ALL, lymphoma, renal tumors, liver tumors, retinoblastoma, soft tissue tumors is lower than that reported in developed countries while survival for CNS tumors, neuroblastoma and germ cell tumors is comparable.

한국과 일본의 사망률 비교 분석을 통한 건강증진정책 함의 (A comparative study for the development of a health promotion policy through an analysis of the mortality rates in Korea and Japan, $1983{\sim}2003$)

  • Nam, Eun-Woo;Song, Yea-Li-A;Moriyama, Masaki;Ishihara, Akiko
    • 보건교육건강증진학회지
    • /
    • 제24권5호
    • /
    • pp.39-54
    • /
    • 2007
  • 본 연구는 1983년부터 2003년까지 21년간의 한국과 일본의 사망통계자료를 이용하여 두 나라간의 사망원인을 비교 분석하였다. 사망률은 일본의 2003년 인구를 표준인구로 한 직접법을 통해 표준화되었다. 분석 결과, 2001/2003년에 한국과 일본의 주요사인의 순위가 크게 바뀌어 가고 있음을 알 수 있었다. 즉, 한국에서는 악성신생물, 당뇨, 신부전, 추락, 자살로 인한 사망률이 증가하였고, 일본에서는 당뇨보다는 폐렴으로 인한 사망률이 증가하고 있었다. 또한, 2001/2003년에는 만성질환으로 인한 사망률의 비율이 급성질환으로 인해 사망하는 경우가 많았다. 이상의 분석 결과, 한국의 건강증진사업은 악성신생물, 당뇨, 신부전, 추락사고, 그리고 자살의 예방과 관리에 대한 다양한 사업이 필요함을 알 수 있었다. 또한, 노인 인구가 많은 일본의 경우, 폐렴으로 인한 사망자가 증가하는 경향을 볼 때에, 한국의 경우도 노인의 경우 폐렴 관련 건강관리가 필요함을 시사하고 있다.

Gemcitabine을 사용한 폐암환자에서 발생한 용혈성 요독증후군 1예 (A Case of Hemolytic Uremic Syndrome in a Lung Cancer Patient Treated with Gemcitabine)

  • 박윤정;양근석;정홍순;남희철;정승혜;김부경;김가영;김정호;김영옥;윤유선
    • Tuberculosis and Respiratory Diseases
    • /
    • 제72권2호
    • /
    • pp.207-211
    • /
    • 2012
  • Hemolytic uremic syndrome (HUS) is a rare disorder characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. HUS arises from a wide spectrum of conditions, and chemotherapeutic agents have been reported to be associated with HUS, including Mitomycin, Cisplatin, Bleomycin, and Gemcitabine. A 76-year-old man treated with Gemcitabine due to non-small cell lung cancer developed clinical and laboratory findings compatible with HUS. Gemcitabine was ceased and hemodialysis and plasma exchange were utilized and he recovered. A high level of suspicion for HUS is necessary when cancer patients are treated with Gemcitabine, and prompt recognition and treatment are also essential.

하대정맥에 발생한 평활근육종 - 1예 보고 - (Leiomyosarcoma of the Inferior Vena Cava - A case report -)

  • 박재홍;김명영;황상원;김한용;유병하
    • Journal of Chest Surgery
    • /
    • 제42권2호
    • /
    • pp.275-278
    • /
    • 2009
  • 하대정맥에 생기는 평활근육종은 매우 드문 악성종양이다. 평활근육에서 기원하는 종양은 대정맥의 가장 흔한 원발성 종양이며, 하대정맥이 가장 흔히 발생하는 곳이다. 환자는 65세의 여자 환자로 입원 3주전부터 시작된 호흡곤란과 복부 불쾌감을 호소하여 내원 하였다. 복부 전산화 단층촬영과 하대정맥 조영술에서 우심방에서 우측 신정맥 위까지 확장된 하대정맥 종양이 보였으며, 또한 하대정맥을 폐쇄시키고 있었다. 하대정맥의 평활근육종으로 진단 후 수술은 종양을 제거하고, 하대정맥을 인조혈관 패치를 이용하여 재건하였다. 수술 후 6개월 간의 추적 관찰 중에 실시한 복부 전산화 단층촬영에서 재발과 하대정맥의 폐쇄소견은 없었다.

Endobronchial Metastases from Extrathoracic Malignancies: Recent 10 Years' Experience in a Single University Hospital

  • Kim, Jung-Hyun;Min, Daniel;Song, Sang-Hee;Lee, Ji-Hyun;Jeong, Hye-Cheol;Kim, Eun-Kyung
    • Tuberculosis and Respiratory Diseases
    • /
    • 제74권4호
    • /
    • pp.169-176
    • /
    • 2013
  • Background: Although the lung is a common site of metastasis, endobronchial metastases (EBM) from extrathoracic malignancies are rare. Previous studies were retrospective reviews of the cases from each single institute, and the last one was performed between 1992 and 2002. We evaluated the characteristics of patients with EBM who had been diagnosed in recent 10 years in our hospital. Methods: We retrospectively reviewed 1,275 patients who had undergone diagnostic bronchoscopic procedures between 2001 and 2011. An EBM was defined as bronchoscopically notable lesion, which was histopathologically identical to the primary tumor. Results: A total of 18 cases of EBM were identified. The mean age was 53 years, and 12 cases of the 18 patients were female. The most common primary malignancies were colorectal cancer and breast cancer (4 cases each), followed by cervix cancer (3 cases) and renal cell carcinoma (2 cases). Cough was the most common symptom. The most common radiologic finding was atelectasis, which was identified in 27.7% of the cases. The median interval from the diagnosis of primary malignancy to the diagnosis of EBM was 14 months (range, 0-112 months). The median survival time from the diagnosis of EBM was 10 months (range, 1-39 months). Conclusion: EBM from extrathoracic malignancies were rare. Colorectal cancer and breast cancer were common as primary malignancies. Fiberoptic bronchoscopy should be performed in all patients, who are suspected of having EBM. If atypical clinical and pathological features are present, appropriate diagnostic studies should be undertaken.

Surgical Treatment for Non-Small Cell Lung Cancer in Patients on Hemodialysis due to Chronic Kidney Disease: Clinical Outcome and Intermediate-Term Results

  • Park, Byung Jo;Shin, Sumin;Kim, Hong Kwan;Choi, Yong Soo;Kim, Jhingook;Shim, Young Mog
    • Journal of Chest Surgery
    • /
    • 제48권3호
    • /
    • pp.193-198
    • /
    • 2015
  • Background: Patients on dialysis undergoing surgery belong to a high-risk group. Only a few studies have evaluated the outcome of major thoracic surgical procedures in dialysis patients. We evaluated the outcomes of pulmonary resection for non-small cell lung cancer (NSCLC) in patients on hemodialysis (HD). Methods: Between 2008 and 2013, seven patients on HD underwent pulmonary resection for NSCLC at our institution. We retrospectively reviewed their surgical outcomes and prognoses. Results: The median duration of HD before surgery was 55.0 months. Five patients underwent lobectomy and two patients underwent wedge resection. Postoperative morbidity occurred in three patients, including pulmonary edema combined with pneumonia, cerebral infarction, and delirium. There were no instances of in-hospital mortality, although one patient died of intracranial bleeding 15 days after discharge. During follow-up, three patients (one patient with pathologic stage IIB NSCLC and two patients with pathologic stage IIIA NSCLC) experienced recurrence and died as a result of the progression of the cancer, while the remaining three patients (with pathologic stage I NSCLC) are alive with no evidence of disease. Conclusion: Surgery for NSCLC in HD patients can be performed with acceptable perioperative morbidity. Good medium-term survival in patients with pathologic stage I NSCLC can also be expected. Pulmonary resection seems to be the proper treatment option for dialysis patients with stage I NSCLC.

심장에 발생한 종양의 수술적 치료 (Surgical Treatment of Cardiac Tumor)

  • 정태은;한승세;이동협
    • Journal of Chest Surgery
    • /
    • 제39권11호
    • /
    • pp.810-814
    • /
    • 2006
  • 배경: 심장에 발생하는 종양은 흔치 않다. 심장종양의 종양에 대한 임상적 특징과 수술 결과를 조사하였다. 대상 및 방법: 1990년 3월부터 2005년 12월까지 35명(남자14명, 여자 21명)의 환자를 대상으로 하였으며 평균 나이는 52.4세였다. 임상 및 병리학적 조사를 후향적으로 시행하였다. 수술은 좌심실 섬유종 1예를 제외한 전 예에서 완전 절제술을 시행하였다. 결과: 양성은 30예였으며 그중 점액종이 29예, 섬유종이 1예였다. 악성은 5예로 골육종, 미분류 점액성 육종, 간세포암, 신세포암, 그리고 난황낭암이 각 1예였다. 양성인 경우 수술 사망은 없었으며 완전절제 후 추적이 가능했던 27예의 경우 재발된 예는 없었다. 악성의 경우 4예가 술 후 6개월 이내에 사망하였다. 결론: 좌심방의 점액종이 가장 많았으며 양성의 경우 외과적 치료는 효과적이었으나 악성인 경우 예후는 매우 불량하였다.

The Early Experience of Laparoscopy-assisted Gastrectomy for Gastric Cancer at a Low-volume Center

  • Yang, Shi-Jun;Ahn, Eun-Jung;Park, Sei-Hyeog;Kim, Jong-Heung;Park, Jong-Min
    • Journal of Gastric Cancer
    • /
    • 제10권4호
    • /
    • pp.241-246
    • /
    • 2010
  • Purpose: Laparoscopy-assisted gastrectomy (LAG) has become a technically feasible and safe procedure for early gastric cancer treatment. LAG is being increasingly performed in many centers; however, there have been few reports regarding LAG at low-volume centers. The aim of this study was to report our early experience with LAG in patients with gastric cancer at a low-volume center. Materials and Methods: The clinicopathologic data and surgical outcomes of 39 patients who underwent LAG for gastric cancer between April 2007 and March 2010 were retrospectively reviewed. Results: The mean age was 68.3 years. Thirty-one patients had medical co-morbidities. The mean patient ASA score was 2.0. Among the 39 patients, 4 patients underwent total gastrectomy and 35 patients underwent distal gastrectomy. The mean blood loss was 145.4 ml and the mean operative time was 259.4 minutes. The mean time-to-first flatus, first oral intake, and the postoperative hospital stay was 2.8, 3.1, and 9.3 days, respectively. The 30-day mortality rate was 0%. Postoperative complications developed in 9 patients, as follows: anastomotic leakage, 1; wound infection, 1; gastric stasis, 2; postoperative ileus, 1; pneumonia, 1; cerebral infarction, 1; chronic renal failure, 1; and postoperative psychosis, 1. Conclusions: LAG is technically feasible and can be performed safely at a low-volume center, but an experienced surgical team and careful patient selection are necessary. Furthermore, for early mastery of the learning curve for LAG, surgeons need education and training in addition to an accumulation of cases.